Bioorthogonal chemistry for prodrug activation in vivo.

Prodrugs have emerged as a major strategy for addressing clinical challenges by improving drug pharmacokinetics, reducing toxicity, and enhancing treatment efficacy. The emergence of new bioorthogonal chemistry has greatly facilitated the development of prodrug strategies, enabling their activation through chemical and physical stimuli. This "on-demand" activation using bioorthogonal chemistry has revolutionized the research and development of prodrugs. Consequently, prodrug activation has garnered significant attention and emerged as an exciting field of translational research. This review summarizes the latest advancements in prodrug activation by utilizing bioorthogonal chemistry and mainly focuses on the activation of small-molecule prodrugs and antibody-drug conjugates. In addition, this review also discusses the opportunities and challenges of translating these advancements into clinical practice.

Citation

Qunfeng Fu, Siyong Shen, Pengwei Sun, Zhi Gu, Yifei Bai, Xianglin Wang, Zhibo Liu. Bioorthogonal chemistry for prodrug activation in vivo. Chemical Society reviews. 2023 Nov 13;52(22):7737-7772

Mesh Tags

Substances

PMID: 37905601

search → result